HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Rectal Cancer

Rectal Cancer

Rectal cancer, a subset of colorectal cancer, arises in the last several inches of the large intestine. Research into rectal cancer spans various domains, from early detection methods to innovative treatments. Screening through colonoscopies or fecal occult blood tests helps identify precancerous polyps or early-stage tumors, enhancing prognosis. Advances in imaging technologies like MRI and CT scans enable precise staging, guiding treatment decisions. Therapeutic approaches include surgery, chemotherapy, radiation therapy, and emerging immunotherapies tailored to individual genetic profiles. Targeted therapies, such as EGFR inhibitors, offer promising avenues for patients with specific genetic mutations. Moreover, ongoing studies explore the role of lifestyle modifications and dietary interventions in preventing rectal cancer development and recurrence. Comprehensive research efforts aim to improve outcomes and quality of life for individuals affected by this disease.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp